Medtronic, Johnson & Johnson among active players in $410B medical devices market

Written by Mackenzie Garrity | February 05, 2019 | Print  |

The medical devices market is expected to see dramatic growth in the coming years, reaching $410 billion by 2023.

Today, Medtronic and Johnson & Johnson are among some of the top active healthcare stocks on the market.

What makes Johnson & Johnson notable is its recent TECNIS Eyhance IOL launch in Europe. This was a first in the monofocal IOL category, as most lenses today only correct vision to help patients with cataracts see things at a distance.

Medtronic has also made headlines. The company announced the first U.S. patients were treated with the Mazor X Stealth Edition for spine surgery. The system offers a fully-integrated procedural solution for surgical planning, workflow, execution and confirmation.

"It is rare that huge sectors of technology such as robotics and navigation merge into a sole platform as found in the Mazor X Stealth Edition. Combined, these may provide more predictable and reliable execution of our procedure workflows," said Jeffrey Gum, M.D., orthopedic spine surgeon at Norton Leatherman Spine Center in Louisville, Ky. "Computerized surgical planning, 3D assessment of spine anatomy, robotic guidance and live navigation feedback are designed to provide a higher degree of accuracy throughout the surgical procedure."

The report also acknowledged BioSig Technologies, Cardinal Health and Abbott Laboratories.

To read the full report, click here.

More articles on devices and implants:
Orthofix acquires Options Medical: 3 things to know
Spinal surgical robots market to exceed $380M by 2024 with 33.6% CAGR: 4 details
Corin Group names new president: 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months